Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001209191-19-050148

CEO acquired 57,612 shares (option exercise)

  • CEO gave up 17,230 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
PIMSTONE SIMON N. CEO 2019-09-17 Option exercise +36,008 $3.70 $133,230 264,143 D
PIMSTONE SIMON N. CEO 2019-09-17 Shares withheld for taxes −10,769 $9.44 $101,659 253,374 D
PIMSTONE SIMON N. CEO 2019-09-17 Option exercise +9,259 $3.07 $28,425 262,633 D
PIMSTONE SIMON N. CEO 2019-09-17 Shares withheld for taxes −2,769 $9.44 $26,139 259,864 D
PIMSTONE SIMON N. CEO 2019-09-17 Option exercise +12,345 $3.38 $41,726 272,209 D
PIMSTONE SIMON N. CEO 2019-09-17 Shares withheld for taxes −3,692 $9.44 $34,852 268,517 D
Derivatives
PIMSTONE SIMON N. CEO 2019-09-16 Grant or award · Stock Option (Right to Buy) +280,000 280,000 D
PIMSTONE SIMON N. CEO 2019-09-17 Option exercise · Stock Option (Right to Buy) −36,008 0 D
PIMSTONE SIMON N. CEO 2019-09-17 Option exercise · Stock Option (Right to Buy) −9,259 0 D
PIMSTONE SIMON N. CEO 2019-09-17 Option exercise · Stock Option (Right to Buy) −12,345 0 D
Loading xslF345X03/doc4.xml…